- Anti-tumor activity of splice-switching oligonucleotidesJohn A Bauman
Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA
Nucleic Acids Res 38:8348-56. 2010..Our findings demonstrate in vivo anti-tumor activity of SSOs that modulate Bcl-x pre-mRNA splicing...
- Modulation of RNA splicing as a potential treatment for cancerJohn A Bauman
Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, USA
Bioeng Bugs 2:125-8. 2011..g., ∆7TNFR1), and they have recently progressed to clinical trials for patients with Duchenne muscular dystrophy. ..